EXAMINATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: SUBGROUP ANALYSIS OF PHASE 3

被引：0
|
作者：
Howard, James
Bril, Vera
Vu, Tuan
Karam, Chafic
Peric, Stojan
De Bleecker, Jan L.
Murai, Hiroyuki
Pasnoor, Mamatha
Sacca, Francesco
Meisel, Andreas
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
机构：
来源：
MUSCLE & NERVE | 2021年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
6
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [1] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF THE ADAPT AND ADAPT plus STUDIES
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Pasnoor, Mamatha
    Sacca, Francesco
    Meisel, Andreas
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 65 : S13 - S14
  • [2] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF ADAPT/ADAPT
    Vu, Tuan
    Bril, Vera
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Pasnoor, Mamatha
    Sacca, Francesco
    Meisel, Andreas
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Mantegazza, Renato
    Howard, James
    MUSCLE & NERVE, 2022, 66 : S54 - S55
  • [3] Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    NEUROLOGY, 2021, 96 (15)
  • [4] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: phase 3 adapt study results
    Mantegazza, R.
    Bril, V.
    Vu, T.
    Karam, C.
    Peric, S.
    Margania, T.
    Murai, H.
    Biliska, M.
    Shakarishvili, R.
    Smilowski, M.
    Guglietta, A.
    Ulrichts, P.
    Vangeneugden, T.
    Utsugisawa, K.
    Verschuuren, J.
    Howard, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 80 - 80
  • [5] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results
    Mantegazza, Renato
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Howard, James
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [6] SAFETY AND TOLERABILITY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF INFECTION RISK AND HEMATOLOGICAL CHANGES
    Muppidi, Srikanth
    Pasnoor, Mamatha
    Gelinas, Deborah
    Brauer, Edward
    Kerstens, Rene
    Bhavaraju-Sanka, Ratna
    Howard, James
    MUSCLE & NERVE, 2022, 66 : S104 - S104
  • [7] Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice
    Katyal, Nakul
    Halldorsdottir, Karen
    Govindarajan, Raghav
    Shieh, Perry
    Muley, Suraj
    Reyes, Phoebedel
    Leung, Kenneth K.
    Mullen, Jeffrey
    Milani-Nejad, Shadi
    Korb, Manisha
    Goyal, Namita A.
    Mozaffar, Tahseen
    Goyal, Neelam
    Habib, Ali A.
    Muppidi, Srikanth
    MUSCLE & NERVE, 2023, 68 (05) : 762 - 766
  • [8] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 65 : S9 - S10
  • [9] Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
    Howard, James F. Jr Jr
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Perk, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    LANCET NEUROLOGY, 2021, 20 (07): : 526 - 536
  • [10] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 66 : S57 - S57
12345